Like most doctors, Nathan Sackett got into medicine because he wanted to help patients get better. The only problem? He chose addiction as his specialty, a notoriously difficult area to see improvement in.
“It is a challenging field,” says Sackett, an acting assistant professor of psychiatry and behavioral sciences at the University of Washington School of Medicine. “A lot of people struggle with substance use, and our ability to treat those use disorders is very, very limited.”
In an effort to change that, Sackett is now heading up a study to explore the potential therapeutic value of the psychedelic compound found in mushrooms, psilocybin. Last year, Washington legislators passed
→ Continue reading at SeattleMet